{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T17:13:51Z","timestamp":1773422031414,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,8,31]],"date-time":"2012-08-31T00:00:00Z","timestamp":1346371200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Psychiatry Rep"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s11920-012-0315-6","type":"journal-article","created":{"date-parts":[[2012,8,30]],"date-time":"2012-08-30T03:14:46Z","timestamp":1346296486000},"page":"619-623","source":"Crossref","is-referenced-by-count":16,"title":["Psychotic Depression\u2014Beyond the Antidepressant\/Antipsychotic Combination"],"prefix":"10.1007","volume":"14","author":[{"given":"Erik B.","family":"Nelson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,31]]},"reference":[{"key":"315_CR1","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"1995","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington DC: American Psychiatric Association; 1995."},{"key":"315_CR2","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1001\/archpsyc.1991.01810360039006","volume":"48","author":"J Johnson","year":"1991","unstructured":"Johnson J, Horwath E, Weissman M. The validity of major depression with psychotic features based on a community study. Arch Gen Psychiatry. 1991;48:1075\u201381.","journal-title":"Arch Gen Psychiatry"},{"key":"315_CR3","first-page":"76","volume-title":"Depression and mania","author":"S Roose","year":"1988","unstructured":"Roose S, Glassman A. Delusional depression. In: Georgotas A, Cancro R, editors. Depression and mania. New York: Esevier Science Publishing Co., Inc.; 1988. p. 76\u201385."},{"key":"315_CR4","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1176\/ajp.138.3.328","volume":"138","author":"DS Charney","year":"1981","unstructured":"Charney DS, Nelson JC. Delusional and nondelusional unipolar depression: further evidence for distinct subtypes. Am J Psychiatry. 1981;138:328\u201333.","journal-title":"Am J Psychiatry"},{"key":"315_CR5","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1176\/ajp.138.2.275","volume":"138","author":"A Frances","year":"1981","unstructured":"Frances A, Brown RP, Kocsis JH, Mann JJ. Psychotic depression: a separate entity? Am J Psychiatry. 1981;138:831\u20133.","journal-title":"Am J Psychiatry"},{"key":"315_CR6","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1176\/ajp.149.6.733","volume":"149","author":"A Schatzberg","year":"1992","unstructured":"Schatzberg A, Rothschild A. Psychotic (delusional) depression: should it be included as a distinct syndrome in DSM-IV? Am J Psychiatry. 1992;149:733\u201345.","journal-title":"Am J Psychiatry"},{"key":"315_CR7","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1001\/archpsyc.1982.04290100051008","volume":"39","author":"W Coryell","year":"1982","unstructured":"Coryell W, Tsuang M. Primary unipolar depression and the prognostic importance of delusions. Arch Gen Psychiatry. 1982;39:1181\u20134.","journal-title":"Arch Gen Psychiatry"},{"key":"315_CR8","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1600-0447.1987.tb02755.x","volume":"75","author":"W Coryell","year":"1987","unstructured":"Coryell W, Endicott J, Keller M. The importance of psychotic features to major depression: course and outcome during a 2-year follow-up. Acta Psychiatr Scand. 1987;75:78\u201385. 1Using Smart Source Parsing Jan.","journal-title":"Acta Psychiatr Scand"},{"key":"315_CR9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0165-0327(85)90013-8","volume":"9","author":"DG Robinson","year":"1985","unstructured":"Robinson DG, Spiker DG. Delusional depression: a one year follow-up. J Affect Disord. 1985;9:79\u201383.","journal-title":"J Affect Disord"},{"key":"315_CR10","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0165-0327(94)90086-8","volume":"32","author":"L Lykouras","year":"1994","unstructured":"Lykouras L, Christodoulou GN, Malliaras D, Stefanis C. The prognostic importance of delusions in depression: a 6-year prospective follow-up study. J Affective Disord. 1994;32:233\u20138.","journal-title":"J Affective Disord."},{"issue":"1\u20132","key":"315_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2011.08.028","volume":"136","author":"M Tohen","year":"2012","unstructured":"Tohen M, Khalsa H-MK, Salvatore P, Vieta E, Ravichandran C, Baldessarini RJ. Two-year outcomes in first-episode psychotic depression the McLean-Harvard First-Episode Project. J Affect Disord. 2012;136(1\u20132):1\u20138.","journal-title":"J Affect Disord"},{"issue":"4","key":"315_CR12","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/archgenpsychiatry.2010.179","volume":"68","author":"RH Perlis","year":"2011","unstructured":"\u2022 Perlis RH, Uher R, Ostacher M, et al. Association between bipolar spectrum features and treatment outcomes in outpatients with major depressive disorder. Arch Gen Psychiatry. 2011;68(4):351\u201360. The authors investigated the effect of the presence of recent manic or psychotic symptoms on remission from depression in the STAR*D study. The presence of one \u201cpsychosislike symptom\u201d in the past 2 weeks predicted a poorer response to treatment. A greater score on the psychosislike symptom questionnaire was associated with a greater chance of non-remission with up to four courses of antidepressant treatment.","journal-title":"Arch Gen Psychiatry"},{"key":"315_CR13","first-page":"68","volume":"10","author":"A Rothschild","year":"1985","unstructured":"Rothschild A. Delusional depression: a review of the literature and current perspectives. McLean Hosp J. 1985;10:68\u201384.","journal-title":"McLean Hosp J."},{"key":"315_CR14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0165-0327(91)90047-V","volume":"22","author":"G Parker","year":"1991","unstructured":"Parker G, Hadzi-Pavlovic D, Hickie I, Boyce P, et al. Distinguishing psychotic and non-psychotic melancholia. J Affect Disord. 1991;22:135\u201348. 3Using Smart Source Parsing Jul.","journal-title":"J Affect Disord"},{"key":"315_CR15","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1749-6632.1988.tb42128.x","volume":"537","author":"AF Schatzberg","year":"1988","unstructured":"Schatzberg AF, Rothschild AJ. The roles of glucocorticoid and dopaminergic systems in delusional (psychotic) depression. Ann N Y Acad Sci. 1988;537:462\u201371. Using Smart Source Parsing Oct.","journal-title":"Ann N Y Acad Sci"},{"key":"315_CR16","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/0006-3223(87)90126-0","volume":"22","author":"RF Anton","year":"1987","unstructured":"Anton RF. Urinary free cortisol in psychotic depression. Biol Psychiatry. 1987;22:24\u201334. 1Using Smart Source Parsing Jan.","journal-title":"Biol Psychiatry"},{"key":"315_CR17","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0165-1781(87)90006-0","volume":"20","author":"A Rothschild","year":"1987","unstructured":"Rothschild A, Schatzberg A, Langlais P, et al. Psychotic and nonpsychotic depression: comparison of plasma catecholamines and cortisol measures. Psych Res. 1987;20:143\u201353.","journal-title":"Psych Res."},{"key":"315_CR18","doi-asserted-by":"crossref","unstructured":"\u2022 Lembke A, Gomez R, Tenakoon L, et al. The mineralocorticoid receptor agonist, fludrocortisone, differentially inhibits pituitary-adrenal activity in humans with psychotic major depression. Psychoneuroendocrinology. 2012. The authors measured hourly evening serum cortisol levels from 1800 h to 2300 h in patients with psychotic depression, non-psychotic depression, and healthy volunteers. On 1 of 2 days patients were administered fludrocortisone, a mineralocorticoid receptor (MR) antagonist. The psychotic depression group exhibited a greater area under the curve (AUC) for cortisol, while the non-psychotic depression group showed no difference from the healthy volunteers. The psychotic depression group also exhibited a significantly smaller decrease in cortisol level at 2200 h on the day when fludrocortisone was administered compared with the other groups. The results support previous findings of greater HPA axis dysregulation in psychotic depression and suggest that an imbalance of MR\/GR function is associated with this subtype.","DOI":"10.1016\/j.psyneuen.2012.05.006"},{"issue":"2","key":"315_CR19","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1176\/appi.ajp.2010.09121718","volume":"168","author":"A Garrett","year":"2011","unstructured":"\u2022\u2022 Garrett A, Kelly R, Gomez R, Keller J, Schatzberg AF, Reiss AL. Aberrant brain activation during a working memory task in psychotic major depression. Am J Psychiatry. 2011;168(2):173\u201382. Assessed neural activity during fMRI in patients with psychotic depression, non\u2010psychotic depression, and healthy volunteers using verbal memory tasks. Psychotic depression showed abnormal parahippocampal activation and increased tempoparietal activity associated with memory processing. The latter finding may be associated with deficits in sensory gating.","journal-title":"Am J Psychiatry"},{"key":"315_CR20","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/archpsyc.1976.01770090083008","volume":"33","author":"G Simpson","year":"1976","unstructured":"Simpson G, Lee J, Cuculic Z, Keller R. Two dosages of imipramine in hospitalized endogenous and neurotic depressives. Arch Gen Psych. 1976;33:1093\u2013102.","journal-title":"Arch Gen Psych"},{"key":"315_CR21","first-page":"559","volume":"136","author":"A Glassman","year":"1975","unstructured":"Glassman A, Kantor S, Shostak M. Depression, delusions and drug response. Am J Psychiatry. 1975;136:559\u201362.","journal-title":"Am J Psychiatry"},{"key":"315_CR22","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1600-0447.1986.tb02692.x","volume":"73","author":"EP Lykouras","year":"1986","unstructured":"Lykouras EP, Malliaras D, Christodoulou GN, Papakostas Y, et al. Delusional depression: phenomenology and response to treatment: a prospective study. Acta Psychiatr Scand. 1986;73:324\u20139.","journal-title":"Acta Psychiatr Scand"},{"issue":"8","key":"315_CR23","doi-asserted-by":"crossref","first-page":"959","DOI":"10.4088\/JCP.v64n0817","volume":"64","author":"GM Simpson","year":"2003","unstructured":"Simpson GM, El Sheshai A, Rady A, Kingsbury SJ, Fayek M. Sertraline as monotherapy in the treatment of psychotic and nonpsychotic depression. J Clin Psychiatry. 2003;64(8):959\u201365.","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"315_CR24","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/00124509-200112000-00003","volume":"17","author":"G Petrides","year":"2001","unstructured":"Petrides G, Fink M, Husain MM, et al. ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. J ECT. 2001;17(4):244\u201353.","journal-title":"J ECT."},{"issue":"3","key":"315_CR25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0165-0327(90)90094-O","volume":"19","author":"AC Pande","year":"1990","unstructured":"Pande AC, Grunhaus LJ, Haskett RF, Greden JF. Electroconvulsive therapy in delusional and non-delusional depressive disorder. J Affect Disord. 1990;19(3):215\u20139.","journal-title":"J Affect Disord"},{"issue":"4","key":"315_CR26","first-page":"314","volume":"5","author":"PG Janicak","year":"1989","unstructured":"Janicak PG, Easton MS, Comaty JE, Dowd S, Davis JM. Efficacy of ECT in psychotic and nonpsychotic depression. Convuls Ther. 1989;5(4):314\u201320.","journal-title":"Convuls Ther."},{"issue":"2","key":"315_CR27","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0165-0327(02)00005-8","volume":"74","author":"TK Birkenh\u00e4ger","year":"2003","unstructured":"Birkenh\u00e4ger TK, Pluijms EM, Lucius SAP. ECT response in delusional versus non-delusional depressed inpatients. J Affect Disord. 2003;74(2):191\u20135.","journal-title":"J Affect Disord"},{"issue":"3","key":"315_CR28","first-page":"97","volume":"49","author":"WJ Solan","year":"1988","unstructured":"Solan WJ, Khan A, Avery DH, Cohen S. Psychotic and nonpsychotic depression: comparison of response to ECT. J Clin Psychiatry. 1988;49(3):97\u20139.","journal-title":"J Clin Psychiatry."},{"issue":"3","key":"315_CR29","first-page":"123","volume":"47","author":"CL Rich","year":"1986","unstructured":"Rich CL, Spiker DG, Jewell SW, Neil JF, Phillipson M. ECT response in psychotic versus nonpsychotic unipolar depressives. J Clin Psychiatry. 1986;47(3):123\u20135.","journal-title":"J Clin Psychiatry."},{"issue":"8","key":"315_CR30","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1001\/archgenpsychiatry.2009.79","volume":"66","author":"BS Meyers","year":"2009","unstructured":"Meyers BS, Flint AJ, Rothschild AJ, et al. A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD). Arch Gen Psychiatry. 2009;66(8):838\u201347.","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"315_CR31","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1176\/ajp.156.6.977a","volume":"156","author":"AJ Rothschild","year":"1999","unstructured":"Rothschild AJ, Phillips KA. Selective serotonin reuptake inhibitors and delusional depression. Am J Psychiatry. 1999;156(6):977\u20138.","journal-title":"Am J Psychiatry"},{"key":"315_CR32","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1176\/ajp.142.4.430","volume":"142","author":"DG Spiker","year":"1985","unstructured":"Spiker DG, et al. The pharmacological treatment of delusional depression. Am J Psychiatry. 1985;142:430\u20136.","journal-title":"Am J Psychiatry"},{"key":"315_CR33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0165-0327(92)90056-C","volume":"24","author":"G Parker","year":"1992","unstructured":"Parker G, Roy K, Hadzi-Pavlovic D, Pedic F. Psychotic (delusional) depression: a meta-analysis of physical treatments. J Affect Disord. 1992;24:17\u201324. 1Using Smart Source Parsing Jan.","journal-title":"J Affect Disord"},{"key":"315_CR34","first-page":"216","volume":"44","author":"C Clower","year":"1983","unstructured":"Clower C. Recurrent psychotic unipolar depression. J Clin Psychiatry. 1983;44:216\u20138.","journal-title":"J Clin Psychiatry."},{"issue":"4","key":"315_CR35","doi-asserted-by":"crossref","first-page":"486","DOI":"10.4088\/JCP.11r07324","volume":"73","author":"A Farahani","year":"2012","unstructured":"\u2022 Farahani A, Correll CU. Are antipsychotics or antidepressants needed for psychotic depression? A systematic review and meta-analysis of trials comparing antidepressant or antipsychotic monotherapy with combination treatment. J Clin Psychiatry. 2012;73(4):486\u201396. Analysis of the combined results of randomized controlled studies that compared an antidepressant-antipsychotic combination to either antidepressant or antipsychotic monotherapy demonstrated a significant advantage in favor of combination treatment over monotherapy. Sub-analyses suggest that a first generation antipsychotic combined with a TCA offers no advantage over monotherapy, while the combination of a second generation antipsychotic with a non-TCA treatment may be superior to monotherapy.","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"315_CR36","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/00004714-200110000-00009","volume":"21","author":"JK Belanoff","year":"2001","unstructured":"Belanoff JK, Flores BH, Kalezhan M, Sund B, Schatzberg AF. Rapid reversal of psychotic depression using mifepristone. J Clin Psychopharmacol. 2001;21(5):516\u201321.","journal-title":"J Clin Psychopharmacol"},{"issue":"5","key":"315_CR37","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0006-3223(02)01432-4","volume":"52","author":"JK Belanoff","year":"2002","unstructured":"Belanoff JK, Rothschild AJ, Cassidy F, et al. An open label trial of C-1073 (mifepristone) for psychotic major depression. Biol Psychiatry. 2002;52(5):386\u201392.","journal-title":"Biol Psychiatry"},{"issue":"12","key":"315_CR38","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.biopsych.2006.05.034","volume":"60","author":"C DeBattista","year":"2006","unstructured":"DeBattista C, Belanoff J, Glass S, et al. Mifepristone versus placebo in the treatment of psychosis in patients with psychotic major depression. Biol Psychiatry. 2006;60(12):1343\u20139.","journal-title":"Biol Psychiatry"},{"issue":"3","key":"315_CR39","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/sj.npp.1300884","volume":"31","author":"BH Flores","year":"2006","unstructured":"Flores BH, Kenna H, Keller J, Solvason HB, Schatzberg AF. Clinical and biological effects of mifepristone treatment for psychotic depression. Neuropsychopharmacology. 2006;31(3):628\u201336.","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"315_CR40","first-page":"563","volume":"8","author":"ND Nihalani","year":"2007","unstructured":"Nihalani ND, Schwartz TL. Mifepristone, a glucocorticoid antagonist for the potential treatment of psychotic major depression. Curr Opin Investig Drugs. 2007;8(7):563\u20139.","journal-title":"Curr Opin Investig Drugs."},{"issue":"5","key":"315_CR41","doi-asserted-by":"crossref","first-page":"598","DOI":"10.4088\/JCP.v66n0509","volume":"66","author":"GM Simpson","year":"2005","unstructured":"Simpson GM, El Sheshai A, Loza N, et al. An 8-week open-label trial of a 6-day course of mifepristone for the treatment of psychotic depression. J Clin Psychiatry. 2005;66(5):598\u2013602.","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"315_CR42","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.cct.2009.03.001","volume":"30","author":"CM Blasey","year":"2009","unstructured":"\u2022\u2022 Blasey CM, Debattista C, Roe R, Block T, Belanoff JK. A multisite trial of mifepristone for the treatment of psychotic depression: a site-by-treatment interaction. Contemp Clin Trials. 2009;30(4):284\u20138. A multicenter placebo-controlled clinical trial designed to investigate whether 7 days of treatment with mifepristone 300-mg, 600-mg or 1,200-mg augmentation resulted in greater response to treatment. Although mifepristone augmentation did not result in a greater percentage of patients responding compared with placebo, a significantly greater percentage of patients responded in the group that had mifepristone plasma levels above 1,660 ng\/ml. The authors comment that an ongoing study that is designed to produce higher plasma concentrations in patients who receive mifepristone may have a greater chance of demonstrating the effectiveness of this drug.","journal-title":"Contemp Clin Trials"},{"issue":"7","key":"315_CR43","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jpsychires.2011.01.003","volume":"45","author":"DM Blumberger","year":"2011","unstructured":"Blumberger DM, Mulsant BH, Emeremni C, et al. Impact of prior pharmacotherapy on remission of psychotic depression in a randomized controlled trial. J Psychiatr Res. 2011;45(7):896\u2013901.","journal-title":"J Psychiatr Res"},{"key":"315_CR44","doi-asserted-by":"crossref","unstructured":"Weissman J, Flint A, Meyers B, et al. Factors associated with non-completion in a double-blind randomized controlled trial of olanzapine plus sertraline versus olanzapine plus placebo for psychotic depression. Psychiatry Research. 2012.","DOI":"10.1016\/j.psychres.2012.02.015"},{"key":"315_CR45","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2165\/00023210-199708060-00004","volume":"8","author":"EB Nelson","year":"1997","unstructured":"Nelson EB, McElroy SL. Psychotic depression: a guide to drug choice. CNS Drugs. 1997;8:457\u201373.","journal-title":"CNS Drugs"}],"container-title":["Current Psychiatry Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-012-0315-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11920-012-0315-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-012-0315-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T02:44:38Z","timestamp":1562121878000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11920-012-0315-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,31]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["315"],"URL":"https:\/\/doi.org\/10.1007\/s11920-012-0315-6","relation":{},"ISSN":["1523-3812","1535-1645"],"issn-type":[{"value":"1523-3812","type":"print"},{"value":"1535-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,31]]}}}